1. A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming
   Lorena Incorvaia et al, 2020, Cancers CrossRef
2. Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers
   Jolanta Kryczka et al, 2021, Diagnostics CrossRef
3. microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
   Ning Wang et al, 2018, Cancers CrossRef
4. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2
   Ru-Jin Zhuang et al, 2019, Cancer Biology & Therapy CrossRef
5. Circulating miRNA 27a and miRNA150-5p; a noninvasive approach to endometrial carcinoma
   Rasha Abdelmawla Ghazala et al, 2021, Molecular Biology Reports CrossRef
6. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer
   Zhen Zhang et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef